Active Ingredient History

  • Now
Nelivaptan (INN) is a selective, orally active, non-peptide vasopressin receptor antagonist selective for the V1B subtype. The drug had entered clinical trials for treatment of anxiety and depression. In July 2008, Sanofi-Aventis announced that further development of this drug had been halted.   Wikipedia

  • SMILES: COc1ccc(c(OC)c1)S(=O)(=O)N2C(=O)[C@](N3C[C@H](O)C[C@H]3C(=O)N(C)C)(c4ccccc4OC)c5cc(Cl)ccc25
  • Mol. Mass: 630.12
  • ALogP: 2.87
  • ChEMBL Molecule:
More Chemistry
1-(5-chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1h-indol-3-yl)-4-hydroxy-n,n-dimethyl-2-pyrrolidinecarboxamide | nelivaptan | sr-149415 | ssr149415 | ssr 149415 | ssr-149415


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue